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Summary The aims of our study were to assess the effect of follow-up on the quality of life of colorectal cancer patients and to assess the
attitudes of patients towards follow-up as a function of patient characteristics. Patients who had been treated with curative intent were
selected from four types of hospitals. Eighty-two patients were interviewed using a structured questionnaire, whereas 130 patients received
the questionnaire by mail. To assess the effect of follow-up on the quality of life, the interviewed patients were randomly allocated to three
groups and interviewed at different times in relation to the follow-up visit. Analysis did not show an effect of the follow-up visit on quality of life.
Patients reported a positive attitude towards follow-up: it reassured them, they judged the communication with the physician to be positive,
and they experienced only slight nervous anticipation and few other disadvantages. Patients reported a strong preference for follow-up, and
a large majority would prefer follow-up even if it would not lead to earlier detection of a recurrence. Apart from living situation, no patient
characteristics were clearly associated with the attitude towards follow-up. Implications for clinical practice are discussed.
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Following curative surgery for colorectal cancer, most patients are
submitted to some- form of oncological follow-up. The main
purpose of this follow-up is to detect recurrences and metachro-
nous tumours in an early phase, when curative treatment may still
be an option. Additional reasons for follow-up may be quality
control for the surgeon and support of the patient (Bruinvels,
1995). The effectiveness and efficiency of oncological follow-up
have become more and more a subject of debate (Deveney and
Way, 1984; Sugarbaker et al, 1987; Isbister, 1988; Loprinzi, 1995;
Virgo et al, 1995). Important effects to be considered in deter-
mining appropriate follow-up practices include longevity, quality
of life and financial implications (Loprinzi, 1995). Effects on
longevity are unclear. Although aggressive surveillance undoubt-
edly detects some cancers before symptoms develop, it is uncer-
tain whether survival is measurably affected (Virgo et al, 1995). In
a recent meta-analysis of studies comparing intensive follow-up
with minimal or no follow-up, no statistically significant differ-
ence in survival was found (Bruinvels et al, 1994).
Little is known about the effects of routine follow-up on the
quality oflife ofcolorectal cancer patients and about the value that
patients attach to follow-up. Breast cancer patients have been
found to experience more psychological complaints and fear of
recurrence just before the follow-up visit (Broyn and Froyen,
1982; Rutgers, 1986). On the other hand, follow-up may have a
positive effect on feelings of security, and the visits may provide
reassurance. In an earlier study from our institute, patients were
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found to experience reduced physical and psychological distress 2
weeks after a follow-up visit compared with immediately
preceding the visit or 1 month beforehand (Kiebert et al, 1993).
The majority ofthese patients had a diagnosis ofbreast cancer. In
a recent large randomized trial in breast cancer, evaluating the
effect of intensive compared with minimalist follow-up, no differ-
ences in health-related quality of life were seen between the two
strategies (GIVIO investigators, 1994). Moreover, neither an
increased anxiety nor stronger reassurance were seen in the inten-
sive follow-up group. Both the study of Kiebert et al (1993) and
the GIVIO study reported that patients had a strong preference for
routine visits. Most studies on the effects of follow-up pertain to
breast cancer (see also Broyn and Froyen, 1982; Rutgers, 1986).
The value ofoncological follow-up in colorectal cancer may differ
from that in breast cancer. Whereas cure in case of metastasized
breast cancer is impossible, surgery with curative intent or long-
term control may still be possible in case of hepatic metastases
from colorectal cancer. Given this potential advantage ofcolorectal
cancerfollow-up, it is ofinterest to assess the attitudes ofcolorectal
cancer patients towards follow-up. Insight into factors that are
associated with a positive or negative attitude, or that influence
feelings ofanxiety orreassurance, may help in determining the best
follow-up schedule for colorectal cancerpatients.
The first purpose of our study was to assess the effect of the
follow-up visit on patients' quality of life. We hypothesized that
patients interviewed shortly after the follow-up visit would have
fewer psychological and physical complaints than patients inter-
viewed immediately before follow-up or halfway between two
visits (Kiebert et al, 1993). The second purpose was to assess the
attitudes ofcolorectal cancer patients towards oncological follow-
up and their strength of preference for follow-up and to see
whether these are associated with patient characteristics (such as
sociodemographics, medical history and quality oflife).
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MATERIALS AND METHODS
Patients
To obtain generalizability, patients were selected from fourdifferent
hospitals: auniversity hospital (Leiden University Hospital), a small
hospital in a large town (Diaconessenhuis, Leiden), a large inner-
city hospital (Leyenburg, The Hague) and a large regional hospital
(Medical Center, Alkmaar). All patients had been treated at or were
in the follow-up protocol of one of the four hospitals, were free of
disease, had had at least two follow-up visits (in order to be able to
express an opinion on follow-up at the time of the study) and had
been treated no more than 5 years before. In the two Leiden hos-
pitals, patients were selected from the outpatient clinic appointment
schedules. To assess whether our samples were selective, we cross-
checked the appointment schedules with the hospital oncology data-
bases to evaluate whether we had missed patients that were lost to
follow-up. In the Leiden University Hospital only fourpatients were
found that should have been in follow-up, but were not. We inter-
viewed those patients to determine whether they had a different
quality of life or attitude towards follow-up. As this was not the
case, we excluded their data from this study as it pertains to an eval-
uation of follow-up. In the Diaconessenhuis, in which we inter-
viewed only a sample of all cases, we randomly selected 25 cases
from the oncology database that were not in the appointment
system. Forall but one case -forwhomthe patient file hadbeen lost
- there were legitimate reasons why the patient did not have an
appointment (moved out of the region, too old, recurrent cancer,
etc.). Thus, we feel confident that the patients interviewed reflect a
population of colorectal cancer patients submitted to follow-up. In
the other two hospitals, patients were selected either from the
hospital oncology database (Medical Center, Alkmaar) or from the
pathology database PALGA/Dutch Network & National Database
for Pathology (Leyenburg Hospital, The Hague).
Procedures
Elicitation mode
In the Leiden University Hospital and Diaconessenhuis, Leiden,
interviews were held, in the context of a larger study assessing the
effectiveness of follow-up in colorectal cancer (Stiggelbout et al,
1995). In the Leyenburgh Hospital, The Hague, and the Medical
Center, Alkmaar, only data on patient attitudes and quality of life
were obtained. These could be collected by means of question-
naires. To assess whether the results ofthe interviews might differ
from those of the questionnaires, we mailed questionnaires to an
additional sample of patients who were from the two hospitals at
which we had conducted the interviews.
Design
To assess the effect of the follow-up visit per se on the quality of
life ofpatients, we compared three patient groups who were inter-
viewed at different times. For this purpose, we randomly divided
the interviewed patients into three subgroups, i.e. those inter-
viewed (a) 1 week before a scheduled follow-up visit, (b) 2 weeks
after a follow-up visit, and (c) in the middle between two follow-
up visits. This procedure was not possible for the patients that
received mailed questionnaires. Data from these patients are there-
fore used only to assess the attitudes towards and strength ofpref-
erence for follow-up.
Quality oflife
Data were obtained using the Medical Outcomes Study short-form
general health survey (MOS SF-20; Stewart et al, 1988) and the
psychological and physical distress scales of the Rotterdam
Symptom Checklist (RSCL; De Haes et al, 1990). The MOS SF-
20 consists of 20 items covering six dimensions: health percep-
tions, physical functioning, mental health, social functioning, role
functioning and pain. The RSCL was developed specifically for
cancer patients. It contains a list of30 items to assess the physical
and psychological distress experienced by the patient in the
preceding week. Finally, the patients rated their overall quality of
life during thepreceding week by means ofa visual analogue scale
(a 100 mmhorizontal line, anchored atthe extremes by 'bestimag-
inable quality oflife' and 'worst imaginable quality oflife').
Within the format of the RSCL, three questions were posed
assessing fear ofrecurrence (see Table 1). These items, also used in
the former study at ourhospital (Kiebert et al, 1993), formed a sepa-
rate factor with satisfactory reliability (Cronbach's alpha = 0.75).
Attitudes towards follow-up
A 16-item questionnaire was developed based on previous research
(Kiebert et al, 1993; see Appendix for details of questionnaire
construction). This follow-up questionnaire consisted of four
subscales: communication (with the physician), reassurance,
nervous anticipation and specific perceived disadvantages of
follow-up. The items and scales are given in Table 2. The following
reliabilities were found: Cronbach's alpha for the disadvantages
scale was 0.45, for the reassurance scale 0.66, for the anticipation
scale 0.71 and for the communication scale 0.81.
Strength ofpreference forfollow-up
In the interviews, an additional preference question was posed. (For
examples of treatment trade-off or treatment preference methods,
see Llewellyn-Thomas et al, 1989; Boyd et al, 1990.) The subject
was asked to imagine a hypothetical choice between follow-up or
no follow-up. It was stressed to the patients that the situation was
Table 1 Fear of recurrence: items of the scalea and distribution of the scores [number (%)]
Not at all Somewhatto some extent Rather Very much
Do you feel insecure about your health? 80 (38) 96 (46) 29 (14) 4 (2)
Do you think the disease might still recur? 46 (24) 107 (55) 29 (15) 11 (6)
Do you feel completely cured? 63 (31) 78 (38) 45 (22) 17 (8)
aCronbach's alpha for the scale was 0.75.
British Journal ofCancer (1997) 75(6), 914-920 0 Cancer Research Campaign 1997916 AM Stiggelbout etal
Table 2 Cancer patients' attitudes towards follow-up: the items of the questionnaire and the distribution of the scores [n (%)]
Factors Not at all Somewhatto some extent Rather Very much
Do the follow-up visits convey you a sense of security? R 11 (5) 34 (16) 80 (38) 84 (40)
Are you nervous before a follow-up visit? A 107 (51) 60 (29) 35 (17) 8 (4)
Are you reassured after the follow-up visit? R 8 (4) 34 (16) 82 (39) 84 (40)
Do you sleep less well in the week before follow-up? A 164 (79) 28 (13) 15 (7) 2 (1)
Would you prefer your family physician to perform the follow-up? D 153 (76) 17 (8) 15 (7) 17 (8)
Can you ask about things at follow-up? C 17 (8) 31 (15) 85 (42) 72 (35)
At follow-up, can you discuss with your doctor matters that C 14 (7) 29 (14) 80 (40) 78 (39)
are of concern to you or about which you worry?
Do you postpone plans till after the follow-up visit? A 148 (72) 26 (13) 22 (11) 11 (5)
Do you think the investigations at follow-up burdensome? D 118 (57) 56 (27) 20 (10) 15 (7)
Do the advantages of follow-up outweigh the disadvantages? R 18 (9) 25 (12) 67 (33) 94 (46)
Would you worry more about your disease if there were no follow-up? R 22 (11) 36 (17) 59 (28) 92 (44)
Do people in the hospital pay attention to what you say? C 5 (3) 11 (5) 104 (51) 83 (41)
Do you normally dread the follow-up visits? A 122 (58) 47 (23) 31 (15) 9 (4)
Does the follow-up remind you each time of your disease, while D 97 (46) 61 (29) 37 (18) 14 (7)
you'd rather think less often about it?
Would you rather have follow-up visits less frequently? A 149 (74) 28 (14) 14 (7) 10 (5)
Do the physicians at follow-up in the hospital have enough time for you? C 11 (5) 11 (5) 120 (59) 61 (30)
aFactors: C, communication; A, nervous anticipation; R, reassurance; D, general disadvantages.
hypothetical, that the true figures were unknown and that the ques-
tion was only aimed atobtaining a measure oftheir strength ofpref-
erence for follow-up. In the 'follow-up' strategy, the chance of
detecting arecurrence in an early stage (in which treatment was still
possible) would be largerthan in the 'no follow-up' strategy (initial
values of 80% and 40% respectively). Subsequently, the chance of
early detection in the 'no follow-up' strategy was increased step-
wise to assess at what (ifany) chance the respondent would switch
to the 'no follow-up' strategy. (If a subject initially preferred the
'no follow-up' strategy, the chances of early detection in this
strategy were decreased to assess at what chance he or she would
switch to 'follow-up.') Thus an impression could be obtained ofthe
strength ofpreference ofthe patient for follow-up.
Sociodemographic data and medical history
Data were collected pertaining to sociodemographics (age, sex,
education, living situation), date ofdiagnosis (orcurative re-resec-
tion), frequency offollow-up and co-morbidity (yes/no).
Data analysis
Scores on the items ofthe psychological and physical distress scale of
the RSCL were coded from 0 to 3 and summed. Scores on the MOS-
SF20 were summed as reported by Stewart et al, (1988) and rescaled
from 0% to 100%. A higher score indicates better functioning for all
dimensions but pain, for which a higher score indicates more pain.
Scores on the follow-up questionnaire were summed (unweighted)
and rescaled from 0% to 100%. For the communication and the reas-
surance scales, a higher score meant a more positive evaluation; for
the nervous anticipation and the disadvantages scale, a higher score
meant more negative effects. The score fromthevisual analogue scale
was the number ofmillimetres from the left endpoint to the mark.
To test for an effect of method of elicitation, data obtained by
interview or by mailed questionnaire were compared and differ-
ences were tested.
The association between subscales and patient characteristics
was tested using Mann-Whitney U-tests and Kruskal-Wallis
analysis of variance. Association between continuous variables
was assessed using Spearman's rank-order correlation coefficient.




Of the 90 patients who were approached for an interview, 82
consented (91%). Of the 120 questionnaires mailed, 105 (87.5%)
were returned completed. Ofthe additional sample of31 question-
naires, mailed to assess an effect of elicitation mode, 25 question-
naires were returned completed (80.6%). This makes a total of 130
questionnaires available for analysis.
In Table 3, patient characteristics for the different groups are
given. Twenty-seven patients were interviewed 1 week before the
scheduled follow-up visit, 27 patients 2 weeks after a follow-up
visit and 28 patients in the middle between two follow-up visits.
Effect of the follow-up visit on the patient's quality of
life
In Table 4 results on the MOS-SF20, the RSCL and the visual
analogue scale (VAS) for quality of life are given for the three
groups, interviewed at three different times in the course offollow-
up. The only differences between the three groups were seen for
the physical functioning scale ofthe MOS-SF20 (P = 0.02) and for
the visual analogue scale (P = 0.09). For both variables, cases
interviewed halfway between two visits scored higher than the
other two groups. As the physical functioning scale of the MOS
pertains to limitations, it is not likely to be affected by a follow-up
visit. On the other hand, overall quality of life (VAS) may very
well be affected by physical limitations. Indeed, the correlation
between physical functioning and the VAS was 0.23 (P = 0.04)
and if we assessed the association between time of interviewing
and VAS, controlling for physical functioning in an analysis of
variance, the association disappeared.
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Table 3 Characteristics of the patient groups by elicitation mode
Elicitation mode
Interviews Mailed questionnaires Total




































0 25 50 75 100







Figure 1 Median scores on the attitude scales, by elicitation mode: interview
(n = 66) vs mailed questionnaire (n = 103). The differences were statistically
significant for the factor anticipation (P < 0.001).
33 (26%) 54 (26%)
Attitudes towards and strength of preference for
follow-up
Attitudes towards follow-up
In Table 2 the scores on the items of the follow-up questionnaire
are given. To the large majority of patients, follow-up conveys a
sense of security and consequently they do not prefer to have
follow-up visits less frequently. Half of the patients (46%) state
that the advantages outweigh the disadvantages to a large extent. It
is remarkable that over halfofthe patients do not indicate thatthey
are nervous or that they dread the follow-up visits. Very few
patients feel that they cannot ask things or discuss problems with
their physician, and very few would prefer follow-up by their
family physician.
In Figure 1, the scores on the follow-up scales are given for the
interviews and the mailed questionnaires. We found significant
differences between the scores from interviews and those from
mailed questionnaires. In general, scores from the interviews were
more positive, suggesting that the interviewed patients gave more
socially desirable answers. Scores from the additional question-
naires, sent to patients from the two hospitals at which the inter-
views had been conducted, were closer to the scores from the
questionnaires in the other two hospitals than to those from the
interviews in the same hospitals. Thus this discrepancy between
scores from interviews and those from questionnaires seems to be
an effect ofmode, not ofregion or hospital.
In general, patients have apositive attitude regarding follow-up.
Scores on the two positive scales (communication with the physi-
cian and reassurance) are much higher than those on the negative
ones (nervous anticipation and general disadvantages). Patients
regard communication with the physician as positive and obtain a
sense ofreassurance from follow-up, whereas they do notperceive
the disadvantages to be large, nor do they indicate feeling much
nervous anticipation.
A positive correlation was seen between communication with
the physician and reassurance (rs= 0.32, P < 0.001) as well
as between nervous anticipation and disadvantages (rs= 0.36,
P < 0.001).
Table 4 Quality of life in patients interviewed at three different times in relation to the follow-up visit: 1 week
before the visit, 2 weeks after the visit and halfway between two visits [medians (interquartile range) and P-value
for test of difference (Kruskal-Wallis one-way ANOVA)]
One week before Two weeks after Halfway P-value
(n = 27) (n = 27) (n=28)
RSCL
Physical 0.18 (0.23) 0.27 (0.50) 0.16 (0.28) 0.32
Psychological 0.13 (0.38) 0.25 (0.75) 0.13 (0.50) 0.43
MOS-SF20
Health perceptions 80 (15) 80 (15) 80 (15) 0.49
Physical 83.3 (33.3) 83.3 (33.3) 100 (14.6) 0.02
Mental 92 (20) 84 (32) 90 (20) 0.70
Social 100 (0) 100 (0) 100 (0) 0.30
Role 100 (0) 100 (0) 100 (0) 0.11
Pain 0 (25) 0 (50) 0 (18.8) 0.39
Visual analogue scale 86 (40) 84 (22) 92.5 (17) 0.09
Fear of recurrence 16.7 (33.3) 22.2 (22.2) 22.2 (33.3) 0.48
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Association with patient characteristics, medical history and
quality oflife
The only statistically significant association with sociodemo-
graphic characteristics was that patients living alone had a more
positive attitude towards follow-up than those who were married
or were living with a sibling or friend (Figure 2). They indicated a
better communication with the physician (P < 0.001), experienced
a stronger sense of reassurance because of follow-up (P = 0.02)
and experienced less general disadvantages of follow-up (P =
0.004) than patients not living alone. As more women than men
lived alone, and women felt a somewhat higher sense of reassur-
ance (median scores 75 and 67, P = 0.09), we analysed this rela-
tionship more closely. An interaction emerged between gender and
living situation: the higher reassurance score for those living alone
only existed for women [medians for those living alone and for
those not living alone were 79 and 71 respectively (P = 0.02); for
men, the corresponding ranks were 71 and 68 (P = 0.55)].
Patients who had yearly follow-up visits indicated more general
disadvantages of follow-up than patients who had 3- or 6-monthly
appointments (medians 22 vs 11 and 11 respectively, P = 0.02).
This was predominantly as aresultofthesepatients indicating more
often that the examinations at follow-up are burdensome and that
follow-up reminds them oftheir disease whereas they would rather
not think about it. Fifty-nine per cent of these patients indicated
examinations to be burdensome to some extent, compared with
40% and 42% in the 3-monthly and 6-monthly group respectively.
Thirty-five percentindicated thatthe visit reminded them too much
oftheirdisease, compared with 23% in the other two groups.
The reassurance scale was associated with interview time in
relation to follow-up. Reassurance was lower in the group inter-
viewed midway between the two visits than in the other two
groups (medians 67 vs 83 and 83 respectively, P = 0.08).
The only attitude scale that correlated with quality of life vari-
ables was the nervous anticipation scale. It correlated with the
psychological distress scale ofthe RSCL(rs= 0.33, P <0.001) and
with fear ofrecurrence (rs= 0.27, P < 0.001). Patients who experi-
enced more psychological distress and more fear of a recurrence
felt more nervous before follow-up visits.
Strength ofpreference forfollow-up
Patients were reluctant to switch to the 'no follow-up' strategy.
The great majority of patients (63%) would not switch at all and
preferred follow-up irrespective of the chances of early detection
(see Table 5). Of the other patients, 10% would only switch to
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Figure 2 Association between living situation and attitude scales: median
scores for patients living alone (n = 42) and those not living alone (n = 126)
Table 5 Treatment preference question: number (%) of patients who
switched from 'follow-up' to 'no follow-up' at various chances of early
detection of a recurrence in the 'no follow-up' strategy (starting point in the
'no follow-up' strategy was a 40% chance of early detection; the hypothetical
chance of early detection for 'follow-up' was held constant at 80%)
n (%)
Switched at early detection rate of:
< 80% 4 (5)
80% 18 (22)
> 80% 7 (9)
Never switched to 'no follow-up' 52 (64)
Total 81 (100)
'no follow-up' if the chances of early detection were more
favourable than in the 'follow-up' strategy. Only one-fifth of
patients switched to 'no follow-up' in the case ofequal chances of
early detection.
For those who were more strongly in favour of follow-up, i.e.
those who always preferred follow-up or who switched only at
more favourable chances in the 'no follow-up' strategy (n = 59),
reassurance was more important than for those who switched at
equal or somewhat lower chances in the 'no follow-up' strategy
(n = 22); median-score values were 83 and 67 respectively (P =
0.02). In addition, they reported less nervous anticipation (median
values 3 and 13, P = 0.09). No association was seen with living
situation, fear ofrecurrence or actual frequency offollow-up visits.
DISCUSSION
We have not found a clear effect of the follow-up visit on the
quality of life of patients with colorectal cancer. The only differ-
ences between the three different interview times were seen for
physical functioning and overall quality oflife. Forboth variables,
the group interviewed midway between two follow-up visits
scored higher than the other two groups. However, we did not
expect physical limitations to be caused by a follow-up visit, and
we did expect quality oflife to be affected by physical limitations.
Indeed, the two variables correlated positively. When the associa-
tion between time of interview and overall quality of life was
adjusted for physical functioning, the association disappeared. We
did, however, expect to find differences in psychological func-
tioning or distress, but this was not the case. Our findings are in
contrast with an earlier study at ouir hospital, which found that the
group interviewed midway between two visits showed less distress
on the RSCL (Kiebert et al, 1993). This may have been due to the
design of our study. For logistic reasons it was not possible to
assess the effect in a longitudinal way, which would have been the
most powerful solution. However, such an assessment shows only
an effect ofthe visit itselfand not the effect ofbeing in a follow-up
programme. A randomized study would be the only way to
compare patients within and outside a follow-up programme. The
GIVIO study (1994) is one such study in breast cancer. In this
study, no differences were seen between intensive and minimalist
follow-up, but both groups were under some form of surveillance.
Moreover, the prospects are different for breast and colorectal
cancer once the disease has metastasized. However, one thing that
can be concluded from both studies at our institute is that, within
British Journal ofCancer (1997) 75(6), 914-920 0 CancerResearch Campaigrz,1997Qualityoflife andattitudes towards follow-up 919
the context of follow-up, a visit does not seem to have a detri-
mental effect on quality of life. The only effect, if any, seems to be
a temporary increase in quality of life following a visit (particu-
larly a visit during which no signs of recurrence were seen).
We have found that patients with colorectal cancer who are
under regular surveillance have a very positive attitude towards
follow-up. They indicate a positive communication with the physi-
cian, a strong sense of reassurance, little nervous anticipation and
few other disadvantages. As very few patients had dropped out of
the follow-up programme, either out of their own will or because
oforganizational problems, our data are likely to be representative
of the colorectal cancer population submitted to follow-up in The
Netherlands. It should be kept in mind, however, that some of our
results may be less applicable to other countries, with for instance
more travel time to the clinic. We found an indication that inter-
viewed patients give more socially desirable answers (Cook et al,
1993): the results from the interviews were even slightly more
positive than those from the mailed questionnaires.
Both a previous study at our institute (Kiebert et al, 1993) and the
GIVIO study (1994) report a positive attitude of cancer patients
towards follow-up, and patients expressed a strong preference for
routine visits. To some extent these findings are not unexpected. It
may be difficult to elicit a negative opinion on follow-up from
patients who feel that non-compliance may jeopardize their life
expectancy. Most ofthe physicians will have presented follow-up as
necessary and will have expressed no doubts to the patients as to the
value of the follow-up. Therefore, such positive attitudes should be
interpreted with caution. It may be a psychological mechanism
through which patients manage to keep their motivation to adhere to
the follow-up protocol. This could explain why subjects interviewed
midway between two visits indicate fewer positive effects and more
disadvantages. They do not have tojustify the visit they are about to
have, or havejust had. It should also be noted that patients who had
yearly follow-up visits indicated more disadvantages of follow-up.
As time goes by and prognosis improves (resulting in a less frequent
follow-up schedule), the negative aspects become more salient. One
of these aspects is the examination at follow-up, which will include
relatively more often burdensome coloscopy. On the other hand,
follow-up reminds patients oftheir cancer when they would perhaps
otherwise think less and less often about their disease.
It is debatable whether the positive attitude of a patient, added to
the temporary increase in well-being after a follow-up visit (Kiebert
et al, 1993), is sufficient grounds for routine follow-up. A large
proportion ofhealth care resources is being targeted at an interven-
tion that may not have the highest priority in an era of scarcity.
Moreover, reassurance may also be seen as anegative factorin cases
for which follow-up is not effective; this could lead to a false sense
of security and to diagnostic delay (Isbister, 1988). To assess
whether follow-up is overall a useful procedure, its cost-effective-
ness should be assessed, taking both survival and quality oflife into
account. In such an analysis, the benefits of follow-up in terms of
life expectancy can be weighed againstthe disadvantages in terms of
earlierdiagnosis ofincurable recurrences in some patients (the diag-
nosis ofincurability being advanced by the so-called lead time).
Should one ever consider abandoning follow-up, based, for
instance, on considerations of cost-effectiveness, our results shed
light on thepsychological barriers that may be encountered. As our
preference question showed, it is very hard for patients to even
consider the idea that 'no follow-up' may be an alternative. The
common opinion in the population seems to be that the diagnosis of
cancer implies routine follow-up, and thus anxiety may be caused if
follow-up were simply abandoned. However, as Brada (1995)
remarked, perhaps patients may not be too distressed about omitting
routine follow-up visits, if armed with correct information of the
lack of value of clinical follow-up. Nevertheless, in these circum-
stances, a plea should be made for a careful process ofabolishing the
visits. A subgroup that may need special attention in this respect
seems to be the group of patients living alone. We found a striking
association between living situation and attitude towards follow-up,
with patients living alone indicating greater advantage overall.
An alternative to routine follow-up by the surgeon or oncologist
may be follow-up by either nurse clinics or by family physicians
(James et al, 1994; Williams, 1994; Wyatt and Aitken, 1994;
Brada, 1995). In particular, if the diagnostic work-up consists only
ofblood tests, such as CEA, both might be reasonable alternatives.
Additionally, identifying patients with low risk of anticipated
medical complications and providing a structure for a phone-based
outpatient consultation may be one way of retaining patient
contact with oncology services and reducing hospital activity
(James et al, 1994). Very few ofour patients indicated a preference
for follow-up by the family physician, partly because of the posi-
tive evaluation of the communication with their specialist.
(Patients who preferred follow-up by their family physician
showed slightly, though not significantly, lower scores on the
communication scale; data not shown.) Therefore, in these circum-
stances, it should be made clear to patients that their family physi-
cian does have the expertise needed and that follow-up by the
surgeon or oncologist does not guarantee a better outcome.
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APPENDIX: DEVELOPMENT OF THE ATTITUDES
TOWARDS FOLLOW-UP QUESTIONNAIRE
In the previous study (Kiebert et al, 1993), a questionnaire had been
used consisting of ten items that pertained to patients' attitudes
regarding regular follow-up. In a factor analysis based on the data
from that study, three (orthogonal) factors or subscales had been
found: a factor pertaining to the communication with the surgeon, a
factor tapping feelings ofnervous anticipation caused by the follow-
upvisitandafactorrelating to some general disadvantages offollow-
up. To improve the reliability (internal consistency) of the
questionnaire, we added six items, one pertaining to nervous antici-
pation, three to general disadvantages and two to communication.
A more stable 4-factor solution was found: the first two original
scales were recovered (communication and nervous anticipation,
explaining 21% and 9% of the variance respectively), a third factor
referred to feelings ofreassurance (explaining 14% ofvariance) and
a final pertained to the disadvantages offollow-up (5% ofvariance).
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